WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002028832) DIINDOLYLMETHANE AND C-SUBSTITUTED DIINDOLYLMETHANE COMPOSITIONS AND METHODS FOR THE TREATMENT OF MULTIPLE CANCERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/028832    International Application No.:    PCT/US2001/042519
Publication Date: 11.04.2002 International Filing Date: 05.10.2001
Chapter 2 Demand Filed:    30.04.2002    
IPC:
A61K 31/404 (2006.01), C07D 209/08 (2006.01)
Applicants: THE TEXAS A & M UNIVERSITY SYSTEM [US/US]; Technology Licensing Office, Mail Stop 3369, College Station, TX 77843 (US)
Inventors: SAFE, Stephen, S.; (US)
Agent: REESE, Raymond, Scott; Howrey Simon Arnold & White, LLP, 750 Bering Drive, Houston, TX 77057-2198 (US)
Priority Data:
60/238,670 06.10.2000 US
60/238,675 06.10.2000 US
Title (EN) DIINDOLYLMETHANE AND C-SUBSTITUTED DIINDOLYLMETHANE COMPOSITIONS AND METHODS FOR THE TREATMENT OF MULTIPLE CANCERS
(FR) COMPOSITIONS DE DIINDOLYLMETHANE ET DE DIINDOLYLMETHANE C-SUBSTITUE ET PROCEDES DE TRAITEMENT DE CANCERS MULTIPLES
Abstract: front page image
(EN)Disclosed are methods and compositions for the treatment of a wide array of cancers and tumors. In illustrative embodiments, diindolylmethanes, C-substituted diindolylmethanes, and analogs thereof have been described, which when administered either alone, or in combination with other anti-cancer or anti-tumorigenic compounds, provide new therapies for the treatment cancer.
(FR)La présente invention concerne des procédés et des compositions destinés au traitement d'un grand ensemble de cancers et de tumeurs. Dans des modes de réalisation représentatifs, des diindolylméthanes, des diindolylméthanes C-substitués et des analogues de ceux-ci fournissent de nouvelles thérapies pour le traitement du cancer, lorsqu'ils sont administrés seuls ou en association avec d'autres composés anticancéreux ou antitumoraux.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)